Intellia Therapeutics Inc (FRA:38I)
€ 13.565 -0.175 (-1.27%) Market Cap: 1.44 Bil Enterprise Value: 903.64 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 57/100

Intellia Therapeutics Inc Annual Shareholders Meeting Transcript

May 21, 2019 / 01:00PM GMT
Release Date Price: €13.81
Operator

Good day, and welcome to the Intellia Therapeutics Incorporated 2019 Annual Meeting of Stockholders. I would now like to turn the conference over to Perry Karsen, Chairman of the company's Board of Directors, to proceed with the 2019 Annual Meeting of Stockholders. Mr. Karsen, please go ahead.

Perry A. Karsen
Intellia Therapeutics, Inc. - Chairman

Thank you. Good morning. I am Perry Karsen, Chairman of the Board of Intellia Therapeutics, Inc. and I will act as Chairman of this meeting. I am pleased to welcome you to the Intellia 2019 Annual Meeting of Stockholders.

Before I call the meeting to order, I would like to introduce you to members of our board and our executive team who are with us today. The other members of the board with us today are: Caroline Dorsa; Dr. Jesse Goodman; Dr. John M. Leonard, our President and Chief Executive Officer; and Dr. Frank Verwiel. The other executive officers of the company with us today are: Glenn Goddard, Executive Vice President and Chief Financial Officer; José Rivera, Executive Vice President, General Counsel

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot